Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). [electronic resource]
Producer: 19840413Description: 91-8 p. digitalISSN:- 0732-183X
- Actuarial Analysis
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bleomycin -- administration & dosage
- Bone Marrow -- drug effects
- Cyclophosphamide -- administration & dosage
- Dexamethasone -- administration & dosage
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Leucovorin -- administration & dosage
- Lymphoma -- drug therapy
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Meningeal Neoplasms -- drug therapy
- Methotrexate -- administration & dosage
- Middle Aged
- Prognosis
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.